Affinity Health

Chicago, Illinois 60644

0 studies enrolling now · 2 studies all time

What they study most

COVID, SARS-CoV-2 Infection

Studies at this site

• Study of Mavrilimumab (KPL-301) in Participants Hospitalized With Severe Corona Virus Disease 2019 (COVID-19) Pneumonia and Hyper-inflammation — Completed
• Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults — Running, not enrolling